Nivolumab in Treating Patients With Relapsed or Refractory Peripheral T-cell Lymphoma
收藏NIAID Data Ecosystem2026-03-10 收录
官方服务：
资源简介：
This phase II trial studies how well nivolumab works in treating patients with peripheral T-cell lymphoma that has come back after a period of improvement or that does not respond to treatment. Monoclonal antibodies, such as nivolumab, may block cancer growth in different ways by targeting certain cells.
创建时间：
2017-05-15
